No Data
BWX Technologies Cut to Underweight From Equal-Weight by Barclays
Barclays Downgrades BWX Technologies to Underweight, Raises Price Target to $90
Barclays Maintains BWX Technologies(BWXT.US) With Sell Rating, Maintains Target Price $90
Barclays Downgrades BWX Technologies(BWXT.US) to Sell Rating, Raises Target Price to $90
Barclays Downgrades BWX Technologies to Underweight From Equalweight, Price Target to $90
BWX Technologies Unit BWXT Medical and NorthStar Collaborating to Produce Cancer-Fighting Isotope